Systemic sclerosis skin is a primed microenvironment for soft tissue calcification-a hypothesis

Area of Science:

• Dermatology
• Rheumatology
• Cell Biology

Background:

• Calcinosis cutis, characterized by sub-epidermal calcium salt deposition, affects 20-40% of patients with systemic sclerosis (SSc).
• Known contributing factors include disease duration, digital ischemia, and acro-osteolysis, but the exact pathogenesis remains unclear.
• Current therapeutic options for SSc-related calcinosis are limited and lack disease-modifying effects.

Purpose of the Study:

• To investigate the underlying mechanisms of calcinosis cutis in systemic sclerosis.
• To explore the role of extracellular matrix (ECM) alterations and fibroblast cellular phenotypes in SSc-related calcification.
• To identify potential therapeutic targets for SSc-related calcinosis.

Main Methods:

• Analysis of pathological changes in the skin extracellular matrix (ECM) following SSc onset.
• Investigation of fibroblast cellular phenotypes and their potential pro-osteogenic profiles.
• Exploration of driving forces contributing to tissue mineralization in SSc.

Main Results:

• Marked changes in the skin ECM, including microfibrillar network breakdown and type I collagen accumulation, are observed post-SSc onset.
• Systemic sclerosis fibroblasts may adopt a pro-osteogenic phenotype, creating a microenvironment conducive to soft tissue calcification.
• Specific factors driving tissue mineralization in SSc are hypothesized.

Conclusions:

• Pathological ECM changes and altered fibroblast behavior are proposed as key mechanisms in SSc-related calcinosis.
• Understanding these mechanisms could illuminate the pathogenesis of SSc-related calcinosis.
• This research may inform the development of novel therapeutic interventions for SSc-related calcinosis.